OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhostUNIVERSITÄT DORTMUND

Select item for more details and to access through your institution.

Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together.
Published in:
Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.790469
By:
- Zhang, Lin;
- Poorbaugh, Josh;
- Dougan, Michael;
- Chen, Peter;
- Gottlieb, Robert L.;
- Huhn, Gregory;
- Beasley, Stephanie;
- Daniels, Montanea;
- Ngoc Vy Trinh, Thi;
- Crisp, Melissa;
- Freitas, Joshua Joaquin;
- Vaillancourt, Peter;
- Patel, Dipak R.;
- Nirula, Ajay;
- Kallewaard, Nicole L.;
- Higgs, Richard E.;
- Benschop, Robert J.
Publication type:
Article
The anti–SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination.
Published in:
Science Translational Medicine, 2022, v. 14, n. 655, p. 1, doi. 10.1126/scitranslmed.abn3041
By:
- Benschop, Robert J.;
- Tuttle, Jay L.;
- Zhang, Lin;
- Poorbaugh, Josh;
- Kallewaard, Nicole L.;
- Vaillancourt, Peter;
- Crisp, Melissa;
- Trinh, Thi Ngoc Vy;
- Freitas, Joshua J.;
- Beasley, Stephanie;
- Daniels, Montanea;
- Haustrup, Natalie;
- Higgs, Richard E.;
- Nirula, Ajay;
- Cohen, Myron S.;
- Marovich, Mary
Publication type:
Article